TY - JOUR
T1 - Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans
AU - Thompson, George R.
AU - Wiederhold, Nathan P.
AU - Fothergill, Annette W.
AU - Vallor, Ana C.
AU - Wickes, Brian L.
AU - Patterson, Thomas F.
PY - 2009/1
Y1 - 2009/1
N2 - We measured antifungal activity against 128 cryptococcal isolates (86 of C. neoformans and 42 of C. gattii) to determine if differences in serotype susceptibility exist. Contrary to previous results, we found no serotype susceptibility differences. Isavuconazole, posaconazole, and voriconazole demonstrated excellent potency against each isolate and serotype, including isolates with reduced fluconazole susceptibilities.
AB - We measured antifungal activity against 128 cryptococcal isolates (86 of C. neoformans and 42 of C. gattii) to determine if differences in serotype susceptibility exist. Contrary to previous results, we found no serotype susceptibility differences. Isavuconazole, posaconazole, and voriconazole demonstrated excellent potency against each isolate and serotype, including isolates with reduced fluconazole susceptibilities.
UR - https://www.scopus.com/pages/publications/59749083143
UR - https://www.scopus.com/pages/publications/59749083143#tab=citedBy
U2 - 10.1128/AAC.01216-08
DO - 10.1128/AAC.01216-08
M3 - Article
C2 - 18955539
AN - SCOPUS:59749083143
SN - 0066-4804
VL - 53
SP - 309
EP - 311
JO - Antimicrobial agents and chemotherapy
JF - Antimicrobial agents and chemotherapy
IS - 1
ER -